Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMNX
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,816
Award facts
- Contract value 100% obligated
- $18,816.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $18,816.01 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This firm fixed-price delivery order, awarded on December 5, 2025, with an ultimate completion date of December 8, 2025, is issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group specializes in distributing a comprehensive range of pharmaceutical products and medical consumables to federal agencies, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical supplies to support Department of Defense healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract, valued at $499,999,999 with a completion date of December 31, 2036, positions DMS Pharmaceutical Group as a regional prime vendor contractor authorized to supply the diverse and specialized pharmaceutical requirements of military healthcare facilities worldwide. The company's established performance on numerous delivery orders demonstrates its capability to fulfill critical pharmaceutical supply needs across the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMNX?
SPE2DU26FEMNX was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 5, 2025.
How much is contract SPE2DU26FEMNX worth?
The government has obligated $18,816 on SPE2DU26FEMNX.
Is contract SPE2DU26FEMNX an order under another contract?
Yes. SPE2DU26FEMNX is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMNX competed?
The extent of competition for SPE2DU26FEMNX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award